Showing results (51-60 of 151) with videos related to
Sort By:
Pageof 16
British Journal of Cancer|November 1, 1982
The radiosensitizer Ro 03-8799 and the concentrations which may be achieved in human tumours: a preliminary studyM I Saunders, S Dische, D Fermont, et al.International Journal of Radiation Oncology, Biology, Physics|September 1, 1984
The clinical testing of Ro 03-8799--pharmacokinetics, toxicology, tissue and tumor concentrationsM I Saunders, P J Anderson, M H Bennett, et al.British Journal of Cancer|June 1, 1995
p53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapyG D Wilson, P I Richman, S Dische, et al.International Journal of Radiation Oncology, Biology, Physics|December 1, 1989
Continuous hyperfractionated accelerated radiotherapy in locally advanced carcinoma of the head and neck regionM I Saunders, S Dische, A Hong, et al.British Journal of Cancer|March 1, 1981
The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluidS Dische, M I Saunders, P J Riley, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1993
Regaud Lecture, Malmö, 1992. The clinical science of radiation oncologyS DischeRadiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 1, 1987
Radiotherapy using the hypoxic cell sensitizer Ro 03-8799 in malignant melanomaS DischeRadiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1991
Radiotherapy and anaemia--the clinical experienceS DischeRadiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 1985
Chemical sensitizers for hypoxic cells: a decade of experience in clinical radiotherapyS DischePageof 16